Do patients with p16-positive oropharyngeal squamous cell carcinoma get more bone metastasis than p16-negative
A S Harris1, R G Thomas1, C D Passant1
1Aneurin Bevan University Health Board,Newport,Cardiff,Wales,UK.
Background:
Oropharyngeal squamous cell carcinoma is thought to rarely metastasise to bone. This study hypothesised that in p16-positive disease there is a significant incidence of bony metastasis.
Methods:
This was an ambispective cohort review. All patients with oropharyngeal squamous cell carcinoma diagnosed and treated at one centre were included.
Results:
A total of 180 consecutive patients were identified over 5 years. Fifteen patients were excluded because of lack of p16 status, none of whom had bony metastasis. The final analysis included 165 patients: 48 (29.09 per cent) in the p16-negative group and 117 (70.91 per cent) in the p16-positive group. Ten patients (8.55 per cent) in the p16-positive group developed bony metastasis, compared with zero in the p16-negative group; this difference was statistically significant (p = 0.036).
Conclusion:
Expression of p16 was associated with an increased incidence in bony metastasis in this cohort. This is the first study to explore this specific question.
More Related Videos
05:06A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Related Concept Videos
Positive, Negative, and Zero Work
Positive and Negative Feedback Loops
Patient-centered Care
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
